E
Etherna Immunotherapies
Niel, Belgium
Founded 2012
Lipid Nanoparticles mRNA Delivery Nanomedicine Cancer Nanotherapy Gene Therapy Delivery Nanobiosensors
About
mRNA immunotherapy company with proprietary LNP delivery technology
Company Details
- Type
- commercial
- Employees
- 50-100
- Funding
- $100M+
Key Products
- TriMix mRNA Platform
- Cancer Immunotherapy